Differential regulation of circSTAG1 in response to ketamine in a chronic stress animal model: a potential role in resistance and susceptibility to the depression-like phenotype

Authors:

Abstract
Major Depressive Disorder (MDD) stands out as a global psychiatric condition with profound social and economic repercussions, garnering substantial attention within the scientific community. Emerging research hints at the pivotal involvement of circular RNAs (circRNAs) in the pathogenesis of depression and the intriguing resilience phenomenon, where individuals remain impervious to depressive symptoms despite exposure to stressors. It has also been shown that circRNAs are associated with the rate of response to ketamine, a fast-acting antidepressant also used in cases of treatment resistance. In particular, Stromal Antigen 1 (STAG1), a gene involved in chromosome segregation, gene transcription, and DNA repair, has recently emerged as a potential regulator of neuronal function. Here we used the Chronic Unpredictable Mild Stress (CUMS) model in male Wistar rats to study three variants of the circSTAG1, derived from the STAG1 gene, and the STAG1 linear transcript in hippocampus of animals stressed and phenotype resilience, also assessing ketamine's impact on treatment-resistant animals. We found that circSTAG1 isoforms and STAG1 mRNA present slightly different correlation to sucrose consumption and differential expression regulation, especially in untreated susceptible animals. It suggests that those isoforms have different regulatory mechanisms. Thus, isoform 1 circSTAG1 is altered in susceptible untreated animals but not in resistant animals’ ones, suggesting a possible role in stress and resistant development or ketamine response. Additionally, circSTAG1 isoforms are modulated by ketamine, displaying differential modulation in susceptible treatment-resistant animals and healthy controls.